Cargando…

Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review

PDAC bone metastases represent a clinical challenge characterized by multifaceted biological entity.

Detalles Bibliográficos
Autores principales:	Argentiero, Antonella, Calabrese, Angela, Solimando, Antonio Giovanni, Notaristefano, Antonio, Panarelli, Marzia M.G., Brunetti, Oronzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787833/ https://www.ncbi.nlm.nih.gov/pubmed/31624620 http://dx.doi.org/10.1002/ccr3.2412

Ejemplares similares

Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic Option
por: Argentiero, Antonella, et al.
Publicado: (2020)

Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
por: Brunetti, Oronzo, et al.
Publicado: (2019)

Immune system and bone microenvironment: rationale for targeted cancer therapies
por: Gnoni, Antonio, et al.
Publicado: (2020)

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study
por: Argentiero, Antonella, et al.
Publicado: (2019)

Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview
por: Argentiero, Antonella, et al.
Publicado: (2019)

Gene Expression Comparison between Alcohol-Exposed versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis
por: Doronzo, Antonio, et al.
Publicado: (2023)

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
por: Brunetti, Oronzo, et al.
Publicado: (2019)

Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue
por: Longo, Vito, et al.
Publicado: (2016)

Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
por: Longo, Vito, et al.
Publicado: (2019)

Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies
por: Gnoni, Antonio, et al.
Publicado: (2019)

Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
por: Argentiero, Antonella, et al.
Publicado: (2020)

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy
por: Brunetti, Oronzo, et al.
Publicado: (2019)

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
por: Porcelli, Letizia, et al.
Publicado: (2019)

A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
por: Shahini, Endrit, et al.
Publicado: (2022)

Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
por: Shahini, Endrit, et al.
Publicado: (2023)

Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis
por: Fujita, Yusuke, et al.
Publicado: (2016)

Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies
por: Ayres Pereira, Marina, et al.
Publicado: (2019)

Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
por: Azzariti, Amalia, et al.
Publicado: (2016)

Subtypes of pancreatic stellate cells and distant metastasis of pancreatic ductal adenocarcinoma
por: Fan, Yuhui, et al.
Publicado: (2020)

Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy
por: Fasano, Rossella, et al.
Publicado: (2021)

Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
por: Burgaletto, Chiara, et al.
Publicado: (2021)

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
por: Buc, Emmanuel, et al.
Publicado: (2014)

Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis
por: Solimando, Antonio Giovanni, et al.
Publicado: (2021)

Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow
por: Solimando, Antonio G., et al.
Publicado: (2022)

Utility of CT to Differentiate Pancreatic Parenchymal Metastasis from Pancreatic Ductal Adenocarcinoma
por: Barat, Maxime, et al.
Publicado: (2021)

Markers of Bone Metabolism in Patients With Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Pezzilli, Raffaele, et al.
Publicado: (2015)

Collision metastasis from prostate adenocarcinoma and pancreatic ductal adenocarcinoma to a lung nodule
por: Mohamed, Ahmed, et al.
Publicado: (2023)

Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma
por: Mardin, Wolf Arif, et al.
Publicado: (2013)

Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma
por: Wang, Yunchao, et al.
Publicado: (2017)

Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
por: Iida‐Norita, Rie, et al.
Publicado: (2019)

The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma
por: Luan, Hong, et al.
Publicado: (2022)

Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice
por: Thomas, Stacy K., et al.
Publicado: (2023)

Angiogenesis in adenosquamous cancer of pancreas
por: Silvestris, Nicola, et al.
Publicado: (2017)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report
por: De Summa, Simona, et al.
Publicado: (2021)

Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma
por: Adwan, H, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uk9hhjtsk7di2epiihtd3ltbr7